Navigation Links
Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
Date:5/20/2011

age chronic labor shortages.
  • Primary tube sampling with random access loading for maximum flexibility and productivity.  Multiple assays can be run from a single sample, and operators have continuous access to samples, reagents and consumables.
  • A customer-driven design, intuitive software for ease of use, and remote diagnostics capabilities.
  • Extensive process controls that include positive sample identification, liquid level detection, reagent dispense verification, and radio frequency identification (RFID) tags on fluid containers.  These controls help reduce the potential for manual errors.
  • A small footprint with a width of 48", a depth of 32", and a height of 69".

  • The PANTHER system complements Gen-Probe's TIGRIS® system, which was the first fully automated, high-throughput molecular testing system for large laboratories.  Since its launch in 2004, more than 550 TIGRIS systems have been installed at high-volume clinical diagnostic and blood screening laboratories around the world.  TIGRIS can process as many as 1,000 patient samples in a day, yielding 2,000 Chlamydia and gonorrhea results with the APTIMA Combo 2 assay.

    The PANTHER system was CE-marked for sale in the European Union late in 2010.

    About Gen-Probe

    Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.  Gen-Probe is headquartered in San Diego and employs approximately 1,400 people. For more information, go to www.gen-probe.com.

    Caution Regarding Forward-Looking Statements

    Any statements in this news release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are f
    '/>"/>

    SOURCE Gen-Probe Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
    2. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
    3. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
    4. Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
    5. Gen-Probe Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk
    6. Gen-Probe to Webcast Two Upcoming Investor Presentations
    7. Neogen Acquires Gen-Probes BioKits Food Safety Business
    8. Patrick J. Sullivan Elected to Gen-Probe Board of Directors
    9. Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
    10. Gen-Probe Announces Webcast of Third Quarter 2010 Earnings Conference Call
    11. Gen-Probe to Webcast Two Upcoming Investor Presentations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/25/2014)... Laboratories, Inc. (NASDAQ: IDXX ) today reported ... 11% versus the prior year period to $390 million. ... of 2014 versus the prior year period was 9%, ... . Earnings per diluted share ("EPS") for the quarter ... year period to $1.10."In the second quarter, we continued ...
    (Date:7/25/2014)... CHICAGO, Ill., July 25, 2014 NOT ... DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE ... LAWS OR REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE: ... ended June 30, 2014. "This was another ... earnings per share above our original guidance and announced plans ...
    (Date:7/24/2014)... OVERLAND PARK, Kan. , July 24, 2014 ... licensing of two compounds that will be added ... agreement with Australian-based CIMTECH Pty Ltd, a biotechnology ... and PAR 122 have shown promise in bone ... a license to develop the compounds for the ...
    Breaking Medicine Technology:IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33IDEXX Laboratories Announces Second Quarter Results 34AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3
    ... March 19, 2012 Novartis Pharmaceuticals Corporation today ... 75 mcg is now available in the US ... is indicated for the long-term maintenance bronchodilator treatment ... obstructive pulmonary disease (COPD), including chronic bronchitis and/or ...
    ... Incorporated (Nasdaq: ARAY ), the premier radiation ... 2012 Industry Excellence Award by Microsoft® as part of the ... be honored at Convergence 2012 , the premier Microsoft ... Texas. The 2012 Customer Excellence Awards, which are ...
    Cached Medicine Technology:Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 2Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 3Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 4Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 5Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 6Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease 7Accuray Receives Microsoft Dynamics® Customer Excellence Award 2Accuray Receives Microsoft Dynamics® Customer Excellence Award 3Accuray Receives Microsoft Dynamics® Customer Excellence Award 4
    (Date:7/26/2014)... According to the Metabolic Enhancement Training program ... bodybuilding program that helps men lose body fat and ... The program also instructs men how to melt fat ... reveals in its review that this program includes a ... get ripped and jacked at the same time. Vkool ...
    (Date:7/26/2014)... July 26, 2014 As the ... the true vision of Xoçai is ... its exclusive and healthy chocolate products. One such ... of cacao, açaí berries and blueberries, an ingredient ... high-antioxidant blend is utilized in all of Xoçai ...
    (Date:7/25/2014)... Ireland (PRWEB) July 26, 2014 ... quality legal help to people who have suffered ... the launch of both their new company, and ... article on the new website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims ... law. The focus of the company is always ...
    (Date:7/25/2014)... (PRWEB) July 25, 2014 In recent years, ... and eager to reverse the symptoms associated with age-related testosterone ... media at large, a new case study from ... benefits of testosterone therapy using bioidentical hormones. , The ... father from Seattle who found himself beginning to feel the ...
    (Date:7/25/2014)... A federal judge has denied defense ... Pinnacle hip lawsuits ( http://www.depuypinnacle-lawsuit.com/ ) selected as ... go before a jury on September 1, 2014, Bernstein ... 18th, U.S. District Judge Ed Kinkeade of the Northern ... may proceed to trial against Johnson & Johnson, the ...
    Breaking Medicine News(10 mins):Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4
    ... available at www.urac.org/bestpractices WASHINGTON, Feb. 13 ... Practices in Health Care Consumer Empowerment and Protection Conference ... In addition to Ian Morrison,s opening keynote address ... for Value for All Americans , and Lee Woodruff,s ...
    ... Medical Inc. (NYSE: SMA ), a leading independent ... other medical markets, announced today that Brian S. Moore, President ... President and Chief Financial Officer, are scheduled to present at ... Nevada, Las Vegas on Tuesday, February 24, 2009 at ...
    ... 13 Micromet, Inc. (Nasdaq: MITI ), today announced that ... Annual Orange County Growth Stock Conference at the Ritz-Carlton Laguna Niguel on ... Annual Orange County Growth Stock Conference, Date: ... Pacific Time, Place: The Ritz-Carlton Laguna Niguel, ...
    ... Feb. 13 /PRNewswire-Asia/ -- The Hong Kong Sanatorium ... team had,successfully performed a large number of cases ... the application of computer-assisted,navigation system since its first ... hospital in Hong Kong which has acquired the ...
    ... "number sense" appear to be part of the shared ... language to explain abstractions that apparently takes human math ... an assistant professor of psychology and neuroscience at Duke ... monkeys think about numbers without using language. She,s looking ...
    ... SAVANNAH, Ga., Feb. 13 Founders Club will donate $5 ... the Mammography Fund at St. Joseph,s/Candler. "The Mammography Fund ... crucial in the fight against cancer," Jeff Andrews, CEO of ... be sold at Edwin Watts Golf stores and specialty golf ...
    Cached Medicine News:Health News:URAC Announces Agenda for 2009 Best Practices in Health Care Consumer Empowerment and Protection Conference 2Health News:URAC Announces Agenda for 2009 Best Practices in Health Care Consumer Empowerment and Protection Conference 3Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 2Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 3Health News:Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference 4Health News:Navigation System Significantly Improves the Surgical Accuracy of Total Knee Replacement for Arthritis Patients 2Health News:Navigation System Significantly Improves the Surgical Accuracy of Total Knee Replacement for Arthritis Patients 3Health News:Navigation System Significantly Improves the Surgical Accuracy of Total Knee Replacement for Arthritis Patients 4Health News:Pre-verbal number sense common to monkeys, babies, college kids 2Health News:Founders Club Proudly Supports the St. Joseph's/Candler Mammography Fund 2
    Provide 1.5mm protection throughout. Six durable, attractive vinyl coverings are available. Lead glass window factory installed. Larger window available....
    Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
    RayShield Frame Mounted Overhead Lead Acrylic Barriers are offered in a choice of three sizes: 60 cm x 80 cm ( 24" x 32") wide, 60 cm x 50 cm( 24" x 20") wide. Lead acrylic windows of 0.5 mm and 1.0 ...
    Protective Curtain for Barriers can be used on any of our RayShield® Barriers. Whether they are ordered with the barrier or as a retrofit, RayShield Protective Curtains are easy to install with s...
    Medicine Products: